Home › Funds › Stonepine Capital Management, LLC › PLRX

Stonepine Capital Management, LLC position in PLRX

PLIANT THERAPEUTICS INC · Health Care

Stonepine Capital Management, LLC reported holding 414,903 shares of PLRX (PLIANT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$448K, representing 0.34% of its reported portfolio and ranking #49 among its reported holdings. Stonepine Capital Management, LLC has disclosed PLRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)414.90K sh
Reported value held$448.10K
Portfolio Weight0.34%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's PLRX position evolved

Stonepine Capital Management, LLC first disclosed a stake in PLRX in Q3 2025 at 289,237 shares (US$428K). The position peaked in Q3 2026 at 414,903 shares, worth US$448K. Across 5 filings, Stonepine Capital Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 414,903 shares valued at US$448K — an increase of 184,365 shares quarter over quarter.. Notable position changes include a 80% increase in Q3 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 289.24K $428.07K New
Q4 2025 230.05K $280.66K Reduce
Q1 2026 224.65K $283.06K Reduce
Q2 2026 230.54K $262.81K Add
Q3 2026 414.90K $448.10K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PLRX and 13F data

PLRX (PLIANT THERAPEUTICS INC) is a Health Care company. 8 other funds we track also report a position in PLRX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$7.0M), Monaco Asset Management SAM (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PLRX

All PLRX fund holders →

FAQ

How long has Stonepine Capital Management, LLC held PLRX?

Stonepine Capital Management, LLC has disclosed PLRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Stonepine Capital Management, LLC's current position in PLRX?

As of Q3 2026, Stonepine Capital Management, LLC holds 414.90K shares of PLRX (PLIANT THERAPEUTICS INC), valued at $448.10K, representing 0.34% of its reported portfolio and ranking #49.

Has Stonepine Capital Management, LLC been buying or selling PLRX?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in PLRX. The position peaked in Q3 2026 at 414.90K shares.

Which other funds hold PLRX?

Other major institutional holders of PLRX include TANG CAPITAL MANAGEMENT LLC, Monaco Asset Management SAM, among 8 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.